Abstract
Statins exert several beneficial effects on patients with peripheral arterial disease, whether managed conservatively or undergoing open surgical/endovascular procedures. Statins improve perioperative and long-term mortality and morbidity rates in these patients. There is also evidence that statins improve infrainguinal bypass graft patency rates and are associated with reduced graft restenosis and amputation rates in these procedures. This review considers the beneficial effects of statins on patients undergoing infrainguinal bypass graft procedures and discusses the implicated pathomechanisms.
Keywords: Statins, peripheral arterial disease, infrainguinal bypass graft operation perioperative mortality and morbidity, peripheral endovascular procedures, 3-hydroxy-3-methylglutaryl coenzyme A, abdominal aortic aneurysms, extremity functions
Current Vascular Pharmacology
Title:Statins and Infrainguinal Vascular Bypass Procedures
Volume: 11 Issue: 1
Author(s): Kosmas I. Paraskevas, Athanasios D. Giannoukas and Dimitri P. Mikhailidis
Affiliation:
Keywords: Statins, peripheral arterial disease, infrainguinal bypass graft operation perioperative mortality and morbidity, peripheral endovascular procedures, 3-hydroxy-3-methylglutaryl coenzyme A, abdominal aortic aneurysms, extremity functions
Abstract: Statins exert several beneficial effects on patients with peripheral arterial disease, whether managed conservatively or undergoing open surgical/endovascular procedures. Statins improve perioperative and long-term mortality and morbidity rates in these patients. There is also evidence that statins improve infrainguinal bypass graft patency rates and are associated with reduced graft restenosis and amputation rates in these procedures. This review considers the beneficial effects of statins on patients undergoing infrainguinal bypass graft procedures and discusses the implicated pathomechanisms.
Export Options
About this article
Cite this article as:
I. Paraskevas Kosmas, D. Giannoukas Athanasios and P. Mikhailidis Dimitri, Statins and Infrainguinal Vascular Bypass Procedures, Current Vascular Pharmacology 2013; 11 (1) . https://dx.doi.org/10.2174/1570161111309010051
DOI https://dx.doi.org/10.2174/1570161111309010051 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Systemic Inflammatory Response, Bacterial Translocation and Nitric Oxide Donors
Inflammation & Allergy - Drug Targets (Discontinued) Testosterone Deficiency in Male: A Risk Factor for Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Genetics of Atherosclerosis in Murine Models
Current Drug Targets Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium
Current Signal Transduction Therapy Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury
Current Pharmaceutical Design Animal Models of Atherosclerosis Progression: Current Concepts
Current Drug Targets - Cardiovascular & Hematological Disorders Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)]
Current Pharmaceutical Design Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design Therapeutic Effect of Ribbon-Type Nuclear Factor-κB Decoy Oligonucleotides in a Rat Model of Inflammatory Bowel Disease
Current Gene Therapy Papillary Tumor of the Pineal Region with Parinaud Syndrome: A Case Report
Current Medical Imaging Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage
Current Pharmaceutical Design Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets Heparin-Coated Extracorporeal Circulation Systems in Heart Surgery
Recent Patents on Cardiovascular Drug Discovery Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology
Current Pharmaceutical Design The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?
Current Hypertension Reviews Behçets Disease as an Autoinflammatory Disorder
Current Drug Targets - Inflammation & Allergy Treatment of Periodontitis for the Prevention of Endothelial Dysfunction: A Narrative Review
Current Vascular Pharmacology